5,0
23 mag 2018
Dipendente attuale, più di 5 anni
Torrance, CA
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Very efficiently run company; with a lot of drug discovery programs for pancreatic cancer drugs and also patient derived xeno grafts (PDX) programs for GBM;Liver Cancer CSCs ;CTCs and 3D printed organ systems for tox studies.
Svantaggi
Have to be on your toes to keep up with all programs